ADC Therapeutics (ADCT) Debt Ratio (2020 - 2026)

ADC Therapeutics has disclosed Debt Ratio across 7 years of filings, most recently posting 0.42 for Q2 2026.

• In Q2 2026, Debt Ratio rose 17.25% year-over-year to 0.42; the TTM figure through Jun 2026 stood at 0.42 (up 17.25% YoY), while the FY2025 annual figure was 0.36, up 1.23% from the prior year.
• Debt Ratio came in at 0.42 for Q2 2026 at ADC Therapeutics, up from 0.4 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.42 in Q1 2025 to a low of 0.16 in Q1 2022.
• Average Debt Ratio over 5 years is 0.31, with a median of 0.32 recorded in 2024.
• The largest YoY upside for Debt Ratio was 91.41% in 2022 against a maximum downside of 5.3% in 2022.
• Over 5 years, Debt Ratio stood at 0.27 in 2022, then grew by 15.82% to 0.32 in 2023, then grew by 11.07% to 0.35 in 2024, then rose by 1.23% to 0.36 in 2025, then climbed by 16.85% to 0.42 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.42 in Q2 2026, 0.4 in Q1 2026, and 0.36 in Q4 2025.